Clinical Trials in Denver

Showing 6141-6160 of 13,773 trials

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

NCT04990219

The main purpose of this study is to investigate Lu AG06466 as a treatment for spasticity in participants with multiple sclerosis (MS).

Multiple Sclerosis

H. Lundbeck A/S37 participantsStarted Sep 2021

Denver, Colorado, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +4 more locations

COMPLETED6.3 miles

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

NCT03739307

This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.

Traumatic Brain InjuryPain

Craig Hospital3,805 participantsStarted May 2019

Birmingham, Alabama, United States • Englewood, Colorado, United States • Tampa, Florida, United States +10 more locations

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Find Trials by Condition in Denver

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

Early Iron Exposure on the Gut Microbiota in Young Infants

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

Enhancing Care of the Aged and Dying in Prisons Ph II

Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Sargramostim Use in COVID-19 to Recover Patient Health

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Androgen Reduction in Congenital Adrenal Hyperplasia

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

A Study of Modified Stem Cells in Stable Ischemic Stroke

Improving Quality by Maintaining Accurate Problems in the EHR

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects